The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios
The offer price corresponds to a premium of 142% on the volume-weighted average price during the last three months
The approval marks a significant milestone for the American pharmaceutical company in the field of UC
International Business is expected to register double-digit growth in constant currency terms
Asahi Songwon Colors' shareholding in ALSPL has increased from 78% to 100%
KarXT, Karuna’s lead asset, is a potential first-in-class treatment for Schizophrenia
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition
Both organisations enter into a long- term collaboration to expand patient access in India
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
Subscribe To Our Newsletter & Stay Updated
